The Journal of Organic Chemistry
ARTICLE
formic acid in 95:5 H2O:/MeCN as the mobile phase. Reactions
conducted under microwave conditions were carried out with a CEM
Discover Labmate microwave synthesizer with an internal IR sensor
located at the bottom of the cavity, irradiation at 2450 MHz and
temperature, power and pressure settings at 25 °C, 200 W and 17 bar,
respectively.
2H), 7.39ꢀ7.26 (m, 4H), 2.44 (s, 3H); 13C NMR (125 MHz) δ 163.5,
145.4, 140.0, 135.1, 129.6, 129.4, 129.3, 129.1, 128.5, 21.6; MS (ESI)
m/z 310 [M þ H]þ.
4-Fluoro-N-tosylbenzamide (2j)35. White solid; 1H NMR δ
9.70 (bs, 1H), 8.02 (d, J = 8.1 Hz, 2H), 7.87 (dd, J = 8.4, 5.1, 2H), 7.33 (d,
J = 8.1 Hz, 2H), 7.07 (t, J = 8.4 Hz, 2H), 2.43 (s, 3H); 13C NMR δ 163.6,
145.4, 135.3, 130.8, 130.6, 129.7, 128.6, 127.3, 116.2, 115.9, 21.7. MS
(ESI) m/z 294 [M þ H]þ.
General Procedure for FeCl2 þ Pyridine Catalyzed Amida-
tion of Aldehydes with PhIdNTs or PhIdNNs. To a suspension
of FeCl2 (0.05 mol) and powdered 4 Å MS (400 mg) in CH2Cl2 (2 mL)
was added pyridine (0.2 mmol). After 5 min of stirring, PhIdNTs or
PhIdNNs (1 mmol) was added followed by addition of the aldehyde
(0.5 mmol). The reaction was stirred at room temperature for 18 h (or
1 h under microwave conditions), after which the crude mixture was
filtered through Celite, washed with EtOAc, evaporated to dryness, and
purified by silica gel flash column chromatography (n-hexanes/EtOAc as
eluant) to give the acyl sulfonamide product.
4-Trifluoromethyl-N-tosylbenzamide (2k)6c. White solid; 1H
NMR δ 9.78 (bs, 1H), 8.02 (d, J = 8.2 Hz, 2H), 7.96 (d, J = 8.1 Hz, 2H),
7.65 (d, J = 8.2 Hz, 2H), 7.35 (d, J = 8.1 Hz, 2H), 2.44 (s, 3H); 13C NMR
δ 163.5, 145.7, 135.1, 134.6, 134.4, 129.8, 128.7, 128.5, 125.9, 125.8,
125.1, 21.7; MS (ESI) m/z 344 [M þ H]þ.
4-Acetoxy-N-tosylbenzamide (2l). White solid; mp 138ꢀ
1
139 °C; H NMR δ 9.39 (bs, 1H), 8.02 (d, J = 8.1 Hz, 2H), 7.83 (d,
J = 8.7 Hz, 2H), 7.34 (d, J = 8.4 Hz, 2H), 7.14 (d, J = 8.7 Hz, 2H), 2.43 (s,
3H), 2.32 (s, 3H); 13C NMR δ 163.4, 154.6, 145.3, 129.7, 129.5, 128.7,
122.2, 21.7, 21.1; IR (neat, cmꢀ1) 3018, 2399, 1759, 1705, 1602, 1425,
1165, 1066; MS (ESI) m/z 318 [M þ H]þ; HRMS (ESI) calcd for
C16H16NO5S 334.0749, found 334.0762.
N-Tosylbenzamide (2a)6c. White solid; 1H NMR δ 9.83 (bs, 1H),
8.03 (d, J = 8.1 Hz, 2H), 7.84 (d, J = 7.5 Hz, 2H), 7.48 (t, J = 7.2 Hz, 1H),
7.36 (t, J = 7.5 Hz, 2H), 7.30 (d, J = 8.1 Hz, 2H), 2.39 (s, 3H); 13C NMR
δ 164.6, 145.2, 135.5, 133.5, 131.1, 129.7, 128.9, 128.6, 128.0, 21.7; MS
(ESI) m/z 276 [M þ H]þ.
6c
1
N-(4-Nitrophenylsulfonyl)benzamide (2b)33. White solid;
1H NMR (CD3COCD3, 400 MHz) δ 8.45 (d, J = 8.8 Hz, 2H), 8.37
(d, J = 8.8 Hz, 2H), 7.95 (d, J = 7.6 Hz, 2H), 7.62 (t, J = 7.6 Hz, 1H), 7.48
(t, J = 8.0 Hz, 2H); 13C NMR δ 165.8, 150.7, 145.6, 133.2, 132.1, 129.8,
128.6, 128.4, 124.1; MS (ESI) m/z 307 [M þ H]þ.
2-Methyl-N-tosylbenzamide (2n) . White solid; H NMR δ
9.17 (bs, 1H), 8.00 (d, J = 8.4 Hz, 2H), 7.41 (d, J = 7.5, 1H), 7.34 (d, J =
8.1 Hz, 2H), 7.29ꢀ7.35 (m, 1H), 7.17 (d, J = 7.5, 1H), 7.13ꢀ7.18 (m,
1H), 2.44 (s, 3H), 2.33 (s, 3H); 13C NMR δ 166.5, 145.2, 138.0, 135.6,
132.1, 131.8, 131.6, 129.6, 128.5, 127.5, 125.9, 21.7, 20.1; MS (ESI) m/z
290 [M þ H]þ.
4-Methoxy-N-tosylbenzamide (2c)6c. White solid; 1H NMR δ
9.21 (bs, 1H), 8.02 (d, J = 8.4 Hz, 2H), 7.82 (d, J = 8.4 Hz, 2H), 7.31 (d,
J = 8.1 Hz, 2H), 6.89 (d, J = 8.7 Hz, 2H), 3.82 (s, 3H), 2.42 (s, 3H); 13C
NMR δ 163.8, 145.1, 135.7, 130.0, 129.6, 128.6, 126.5, 123.3, 114.1,
55.5, 21.7; MS (ESI) m/z 306 [M þ H]þ.
6c
1
N-Tosyl-1-napthamide (2o) . Yellow solid; H NMR δ 8.81
(bs, 1H), 8.17 (m, 1H), 8.04 (d, J = 8.4 Hz, 2H), 7.93 (d, J = 8.1 Hz, 1H),
7.82 (m, 1H), 7.65 (dd, J = 7.2, 0.9 Hz, 1H), 7.47ꢀ7.52 (m, 2H),
7.33ꢀ7.42 (m, 3H), 2.45 (s, 3H); 13C NMR δ 165.9, 145.3, 135.5, 133.7,
132.9, 130.0, 129.9, 129.7, 128.6, 128.5, 127.9, 126.8, 126.6, 124.9, 124.4,
21.7; MS (ESI) m/z 326 [M þ H]þ.
4-tert-Butyl-N-tosylbenzamide (2d)34. White solid; 1H NMR δ
9.69 (bs, 1H), 8.05 (d, J = 8.1 Hz, 2H), 7.79 (d, J = 8.1 Hz, 2H), 7.40 (d,
J = 8.4 Hz, 2H), 7.32 (d, J = 8.1 Hz, 2H), 2.41 (s, 3H), 1.27 (s, 9H); 13C
NMR δ 164.4, 157.3, 145.1, 135.7, 129.6, 128.6, 128.2, 127.9, 125.8,
35.1, 31.0, 21.7; MS (ESI) m/z 332 [M þ H]þ.
N-Tosylpropionamide (2p)36. White solid; 1H NMR δ 8.85 (bs,
1H), 7.94 (d, J = 8.4 Hz, 2H), 7.33 (d, J = 8.1 Hz, 2H), 2.43 (s, 3H), 2.29
(q, J = 7.5 Hz, 2H), 1.06 (t, J = 7.5 Hz, 3H); 13C NMR δ 171.8, 145.2,
135.6, 129.7, 128.3, 29.5, 21.7, 8.2; MS (ESI) m/z 228 [M þ H]þ.
3-Methyl-N-tosylbutanamide (2q)37. White solid; 1H NMR δ
8.99 (bs, 1H), 7.95 (d, J = 8.3 Hz, 2H), 7.34 (d, J = 8.2 Hz, 2H), 2.41
(s, 3H), 2.10 (d, J = 6.3 Hz, 2H), 2.00ꢀ2.06 (m, 1H), 0.86 (d, J = 6.6 Hz,
6H); 13C NMR δ 171.1, 145.2, 135.7, 129.7, 128.4, 45.3, 25.7, 22.3, 21.8;
MS (ESI) m/z 256 [M þ H]þ.
4-Isopropyl-N-tosylbenzamide (2e). White solid; mp 155ꢀ
157 °C; 1H NMR δ 9.36 (bs, 1H), 8.05 (d, J = 8.4 Hz, 2H), 7.79 (d, J =
8.4 Hz, 2H), 7.31 (d, J = 8.4 Hz, 2H), 7.23 (d, J = 8.4 Hz, 2H), 2.89 (quin,
J = 6.9 Hz, 1H), 2.40 (s, 3H), 1.19 (d, J = 6.9 Hz, 6H); 13C NMR δ 164.7,
155.0, 145.1, 135.7, 129.6, 128.7, 128.6, 128.3, 126.9, 34.2, 23.6, 21.7; IR
(neat, cmꢀ1) 3273, 3020, 2964, 1697, 1608, 1427, 1215, 1166, 1070; MS
(ESI) m/z 318 [M þ H]þ; HRMS (ESI) calcd for C17H20NO3S
318.1164, found 318.1164.
N-Tosylisobutyramide (2r)37. Pale yellow solid; 1H NMR (400
MHz) δ 8.86 (bs, 1H), 7.95 (d, J = 8.1 Hz, 2H), 7.35 (d, J = 8.1 Hz, 2H),
2.39ꢀ2.46 (m, 4H), 1.09 (d, J = 7.2 Hz, 6H); 13C NMR (100 MHz) δ
175.0, 145.4, 135.7, 129.9, 128.6, 35.9, 22.0, 18.8; MS (ESI) m/z 344
[M þ H]þ.
6c
1
4-Methyl-N-tosylbenzamide (2f) . White solid; H NMR δ
9.56 (bs, 1H), 8.04 (d, J = 8.4 Hz, 2H), 7.73 (d, J = 8.1 Hz, 2H), 7.32 (d,
J = 8.1 Hz, 2H), 7.18 (d, J = 8.1 Hz, 2H), 2.41 (s, 3H), 2.34 (s, 3H); 13C
NMR δ 164.5, 145.1, 144.4, 135.6, 129.6, 129.5, 128.6, 128.3, 128.0,
21.7, 21.6; MS (ESI) m/z 290 [M þ H]þ.
N-Tosylpivalamide (2s)38. Pale yellow solid; 1H NMR δ 8.68 (bs,
1H), 7.95 (d, J = 8.4 Hz, 2H), 7.33 (d, J = 8.4 Hz, 2H), 2.43 (s, 3H), 1.14
(s, 9H); 13C NMR δ 176.0, 145.0, 135.6, 129.6, 128.4, 40.0, 26.7, 21.6;
MS (ESI) m/z 256 [M þ H]þ.
4-Phenyl-N-tosylbenzamide (2g). White solid; mp 200ꢀ
1
202 °C; H NMR δ 9.07 (bs, 1H), 8.07 (d, J = 8.4 Hz, 2H), 7.87 (d,
N-Tosylheptanamide (2t)11. Pale yellow solid; 1H NMR δ 9.19
(bs, 1H), 7.96 (d, J = 8.1 Hz, 2H), 7.34 (d, J = 8.1 Hz, 2H), 2.44 (s, 3H),
2.23 (t, J = 7.5 Hz, 2H), 1.56 (t, J = 6.9 Hz, 2H), 1.20ꢀ1.26 (m, 6H), 0.82
(t, J = 6.9 Hz, 3H); 13C NMR δ 171.5, 145.1, 135.6, 129.6, 128.3, 36.3,
31.3, 28.5, 24.3, 22.4, 21.7, 13.9; MS (ESI) m/z 284 [M þ H]þ.
N-Tosylcyclopropanecarboxamide (2u)11. White solid; 1H
NMR δ 8.88 (bs, 1H), 7.95 (d, J = 8.1 Hz, 2H), 7.34 (d, J = 8.1 Hz,
2H), 2.44 (s, 3H), 1.56ꢀ1.51 (m, 1H), 1.02 (m, 2H), 0.87ꢀ0.83 (m,
2H); 13C NMR δ 172.3, 145.1, 135.6, 129.6, 128.3, 21.7, 14.7, 9.7; MS
(ESI) m/z 240 [M þ H]þ.
J = 8.4 Hz, 2H), 7.65 (d, J = 8.4 Hz, 2H), 7.58 (d, J = 8.1 Hz, 2H),
7.46ꢀ7.35 (m, 5H), 2.44 (s, 3H); 13C NMR δ 164.5, 145.5, 144.6, 139.4,
137.1, 130.7, 129.4, 129.0, 128.8, 128.4, 128.3, 127.1, 127.0, 20.6; IR
(neat, cmꢀ1) 3286, 3018, 1697, 1606, 1425, 1334, 1215, 1165; MS (ESI)
m/z 352 [M þ H]þ; HRMS (ESI) calcd for C20H18NO3S 352.1007,
found 352.0991.
13
1
4-Bromo-N-tosylbenzamide (2h) . White solid; H NMR δ
9.53 (bs, 1H), 8.02 (d, J = 8.4 Hz, 2H), 7.70 (d, J = 8.4 Hz, 2H), 7.54 (d,
J = 8.4 Hz, 2H), 7.35 (d, J = 8.1 Hz, 2H), 2.44 (s, 3H); 13C NMR δ 163.4,
145.0, 134.9, 131.8, 129.6, 129.3, 129.1, 128.2, 21.3; MS (ESI) m/z 354
[M þ H]þ.
N-Tosylcyclopentanecarboxamide (2v)11. White solid; 1H
NMR δ 8.67 (bs, 1H), 7.94 (d, J = 8.4 Hz, 2H), 7.33 (d, J = 8.1 Hz,
2H), 2.62 (m, 1H), 2.43 (s, 3H), 1.51ꢀ1.82 (m, 8H); 13C NMR δ 173.9,
4-Chloro-N-tosylbenzamide (2i)13. Pale yellow solid; 1H NMR
(500 MHz) δ 9.63 (bs, 1H), 8.02 (d, J = 8.4 Hz, 2H), 7.78 (d, J = 8.4 Hz,
4900
dx.doi.org/10.1021/jo200284a |J. Org. Chem. 2011, 76, 4894–4904